Please assess the completion status of the following clinical trial:

Trial Title: Effect of Cocoa Consumption in Cardiovascular and Immune Parameters

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age: 18 - 65 years old~* Resides in Medellín City~* Attached from the contributive regimen of Colombian Health System~* Essential Arterial Hypertension, stage I. Diagnosis less than 3 months.~* Medically indicated non-pharmacological therapy.~* Voluntary desire to consume 50 grams of chocolate per day for 12 weeks.~* Voluntary desire to participate in the trial and sign informed consent.~Exclusion Criteria:~* Suspect of secondary hypertension~* Suspect of injury in target organ~* Presence of diabetes mellitus~* BMI (Body Mass Index) major or equal to 30~* Present smoker or with less than four weeks of abstinence of tobacco~* Consume antiplatelet substances~* Regular consumption of antioxidants, multivitamins, anti-inflammatory medications, drugs for nasal congestion and sibutramine

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Dark chocolate (Type: ACTIVE_COMPARATOR): Presence of 70% cocoa solids
- White chocolate (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).